- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Stryker Corporation (SYK)
The Stryker share price today is 313.22, view NYSE SYK stock exchange data. Track the latest Stryker share price with real-time updates on SYK stock performance including market cap, day range, 52-week range and dividend yield. Access SYK charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
305.00
314.82
52 wk Range
281.00
404.87
SYK is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
305.00314.82
52 wk Range
281.00404.87
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.15%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.15%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SYK Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
389.35
Upside
+24.31%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
11 analysts have revised their earnings upwards for the upcoming period
- Form 8K Stryker Corporation For: 8 May
- Investing.com
- Form 144 Stryker Corp For: 11 May
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
22 Buy
7 Hold
0 Sell
Ratings:
29 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 389.35
(+24.31% Upside)
Stryker Corporation SWOT Analysis
Financial Prowess | Stryker's robust financial health, consistent revenue growth, and strategic acquisitions position it as a formidable player in the medical technology secto |
Market Expansion | Delve into Stryker's entry into the $15 billion venous thromboembolism market through its Inari Medical acquisition, potentially driving substantial future growth |
Innovation Leade | Explore how Stryker's focus on robotics and advanced medical technologies, particularly its Mako system, is reshaping orthopedic surgery and market dynamics |
Analyst Outlook | With price targets ranging from $420 to $450, analysts remain bullish on Stryker's prospects, despite challenges like tariff impacts and integration risks |
Stryker Corporation Earnings Call Summary for Q1/2026
- Stryker Q1 2026 EPS of $2.60 missed forecast of $2.98; revenue $6B vs expected $6.34B due to cyber incident causing 3-week shutdown.
- Cyber attack resulted in ~$375M deferred/lost sales; adjusted gross margin fell 190bps to 63.6%, operating margin down 180bps to 21.1%.
- Stock plunged 6.47% after-hours to $294.73, near 52-week low of $290.22, reflecting investor concerns over operational disruption.
- Company maintained full-year guidance: FY2026 EPS $15.17, revenue $27.3B; FY2027 EPS $16.95, revenue $29.58B despite Q1 miss.
- Mako robotic surgery platform posted record Q1 performance; upcoming Mako 4 shoulder platform launch expected to drive future growth.
Last Updated: 05-05-2026, 10:42 pm
Read Full TranscriptEarnings
Latest Release
30-04-2026
EPS / Forecast
2.60 / 2.98
Revenue / Forecast
6B / 6.34B
Compare SYK to Peers and Sector
Metrics to compare | SYK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSYKPeersSector | |
|---|---|---|---|---|
P/E Ratio | 36.0x | 22.1x | −0.5x | |
PEG Ratio | 2.15 | 0.37 | 0.00 | |
Price/Book | 5.2x | 2.7x | 2.6x | |
Price / LTM Sales | 4.8x | 2.7x | 3.2x | |
Upside (Analyst Target) | 24.4% | 0.0% | 55.3% | |
Fair Value Upside | Unlock | 28.1% | 9.7% | Unlock |
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Stryker (SYK) Share Price Today?
The Stryker share price today is 313.22.
What is the current Stryker (SYK) share price and day range?
As of 19-05-2026, the Stryker share price is 313.22, with a previous close of 306.76. The share price has ranged from 305.00 to 314.82 today, while the 52-week range spans from 281.00 to 404.87.
What Is the Stryker Market Cap?
As of today, Stryker market cap is 120.08B.
Does Stryker Pay Dividends? What's The Current Dividend Yield?
The Stryker dividend yield is 1.15%.
What Is the Stryker (SYK) Share Price Target?
The average 12-month share price target for Stryker is 389.35, with a high estimate of 465 and a low estimate of 315. 22 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +24.31% Upside potential.
What Is Stryker's Earnings Per Share (TTM)?
The Stryker EPS (TTM) is 8.64.
When Is the Next Stryker Earnings Date?
Stryker will release its next earnings report on 30-07-2026.
From a Technical Analysis Perspective, Is SYK a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What Stock Exchange Does Stryker Trade On?
Stryker is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Stryker?
The stock symbol for Stryker is "SYK."
How Many Times Has Stryker Stock Split?
Stryker has split 9 times.
How Many Employees Does Stryker Have?
Stryker has 56000 employees.
What Is the SYK Premarket Price?
SYK's last pre-market stock price is 307.00. The pre-market share volume is 2,790.00, and the stock has changed by 0.24, or 0.08%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.